BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36255645)

  • 21. Histone deacetylase 6 in health and disease.
    Seidel C; Schnekenburger M; Dicato M; Diederich M
    Epigenomics; 2015; 7(1):103-18. PubMed ID: 25687470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond the Selective Inhibition of Histone Deacetylase 6.
    Rodrigues DA; Thota S; Fraga CA
    Mini Rev Med Chem; 2016; 16(14):1175-84. PubMed ID: 27121714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.
    Bazzaro M; Lin Z; Santillan A; Lee MK; Wang MC; Chan KC; Bristow RE; Mazitschek R; Bradner J; Roden RB
    Clin Cancer Res; 2008 Nov; 14(22):7340-7. PubMed ID: 19010849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of Unanchored Polyubiquitin Chains from Influenza Virions.
    Miyake Y; Matthias P; Yamauchi Y
    Methods Mol Biol; 2018; 1836():329-342. PubMed ID: 30151581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6.
    Osko JD; Christianson DW
    Biochemistry; 2019 Dec; 58(49):4912-4924. PubMed ID: 31755702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras.
    Darwish S; Heimburg T; Ridinger J; Herp D; Schmidt M; Romier C; Jung M; Oehme I; Sippl W
    Methods Mol Biol; 2023; 2589():179-193. PubMed ID: 36255625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes.
    Li Y; Shin D; Kwon SH
    FEBS J; 2013 Feb; 280(3):775-93. PubMed ID: 23181831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insights into HDAC6 tubulin deacetylation and its selective inhibition.
    Miyake Y; Keusch JJ; Wang L; Saito M; Hess D; Wang X; Melancon BJ; Helquist P; Gut H; Matthias P
    Nat Chem Biol; 2016 Sep; 12(9):748-54. PubMed ID: 27454931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration.
    Pandey UB; Batlevi Y; Baehrecke EH; Taylor JP
    Autophagy; 2007; 3(6):643-5. PubMed ID: 17912024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6.
    Watson PR; Gupta S; Hosseinzadeh P; Brown BP; Baker D; Christianson DW
    ACS Chem Biol; 2023 Apr; 18(4):959-968. PubMed ID: 37027789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the discovery of potent and selective HDAC6 inhibitors.
    Wang XX; Wan RZ; Liu ZP
    Eur J Med Chem; 2018 Jan; 143():1406-1418. PubMed ID: 29133060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
    Porter NJ; Mahendran A; Breslow R; Christianson DW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity.
    Zhang XH; Qin-Ma ; Wu HP; Khamis MY; Li YH; Ma LY; Liu HM
    J Med Chem; 2021 Feb; 64(3):1362-1391. PubMed ID: 33523672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular defence or viral assist: the dilemma of HDAC6.
    Zheng K; Jiang Y; He Z; Kitazato K; Wang Y
    J Gen Virol; 2017 Mar; 98(3):322-337. PubMed ID: 27959772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity.
    Zhang L; Liu S; Liu N; Zhang Y; Liu M; Li D; Seto E; Yao TP; Shui W; Zhou J
    Protein Cell; 2015 Jan; 6(1):42-54. PubMed ID: 25311840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1/p62.
    Nakashima H; Nguyen T; Goins WF; Chiocca EA
    J Biol Chem; 2015 Jan; 290(3):1485-95. PubMed ID: 25429107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination.
    Boyault C; Sadoul K; Pabion M; Khochbin S
    Oncogene; 2007 Aug; 26(37):5468-76. PubMed ID: 17694087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Computational Approach to Investigate the HDAC6 and HDAC10 Binding Propensity of Psidium guajava-derived Compounds as Potential Anticancer Agents.
    Adewole KE; Ishola AA
    Curr Drug Discov Technol; 2021; 18(3):423-436. PubMed ID: 32357815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells.
    Iaconelli J; Lalonde J; Watmuff B; Liu B; Mazitschek R; Haggarty SJ; Karmacharya R
    ACS Chem Biol; 2017 Aug; 12(8):2139-2148. PubMed ID: 28628306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.